Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Take Your Ocugen Stock Profits and Run If You Haven’t Already

By Josh Enomoto, InvestorPlace Contributor

While OCGN stock produced one of the most remarkable rides in the market, it’s time to get off this train before it derails.

7 Equity Crowdfunding Offerings Worth Your Investment ASAP

By Josh Enomoto, InvestorPlace Contributor

If you’re tired of the same old companies, you may want to direct your dollars to these equity crowdfunding opportunities.

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

By Josh Enomoto, InvestorPlace Contributor

The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable. These seven stocks require caution.

There Is No Need to “YOLO” on HOLO

By Josh Enomoto, InvestorPlace Contributor

With the Holo token dropping sharply from its unbelievable height, contrarians may be tempted to buy, but that might be a mistake.

7 Falling-Knife Stocks You Don’t Want to Catch

By Josh Enomoto, InvestorPlace Contributor

With the market’s rumblings producing plenty of red ink, investors should be careful about not buying into a falling knife.

You Can Afford to Be Extremely Patient With Coinbase Stock

By Josh Enomoto, InvestorPlace Contributor

While Coinbase stock might seem like a discount, investors must realize the risk that we may be in for a long crypto winter.

Once-Bright Light Novavax Stares Into a Dimming Future as Vaccine Also-Ran

By Josh Enomoto, InvestorPlace Contributor

Once a very promising play on the Covid-19 pandemic, Novavax has lost serious momentum, putting NVAX stock under question.

Why You Should Wait Before Loading the Boat with Litecoin

By Josh Enomoto, InvestorPlace Contributor

The original alternative cryptocurrency Litecoin might seem like a great deal but a deep dive into the technicals suggest otherwise.

As Businesses Return to Normal, ZipRecruiter’s IPO Timing Is Fortuitous

By Josh Enomoto, InvestorPlace Contributor

One of the highly anticipated debuts, ZIP stock has the right stuff to rise above what has been a disappointing IPO season.

7 Cheap Stocks to Buy Now Under $10

By Josh Enomoto, InvestorPlace Contributor

While no one likes to see red ink on their portfolio, a key benefit is that you now have more choices regarding cheap stocks to buy.

Load More